Runx1, mmu-mir-106a-363, Ccnd3, and Flt3, but not Smg6, are also specific for p53−/− compared to wild-type, indicating that mutation of these genes is selected for in cells that lack the p19ARF-p53 tumor suppression pathway. This evidence concerns the gene FLT3 and neoplasm.